Abrdn Healthcare Investors (HQH) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | - | - | - | - | - | - | - | - | - | - | - | - |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 5.46M | 5.31M | 4.66M | 5.63M | 4.32M | 3.96M | 3.22M | 3.26M | 3.91M | 5.02M | 3.89M | 3.71M |
| Gross Margin % | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 17.15% | -5.73% | 8.09% | 42.27% | 34.19% | 21.17% | -17.8% | -34.98% | 0.55% | 35.33% | 2.68% | 23.9% |
| Operating Expenses | 5.65M | 5.34M | 5.69M | 5.79M | 5.75M | 6.19M | 6.55M | 6.16M | 5.69M | 5.22M | 5.15M | 5.32M |
| OpEx % of Revenue | 103.46% | 100.59% | 121.92% | 102.9% | 133.2% | 156.56% | 203.73% | 188.67% | 145.33% | 103.95% | 132.37% | 143.46% |
| Selling, General & Admin | 5.65M | 5.34M | 5.69M | 5.79M | 5.75M | 6.19M | 6.55M | 6.16M | 5.69M | 5.22M | 5.15M | 5.32M |
| SG&A % of Revenue | 103.46% | 100.59% | 121.92% | 102.9% | 133.2% | 156.56% | 203.73% | 188.67% | 145.33% | 103.95% | 132.37% | 143.46% |
| Research & Development | - | - | - | - | - | - | - | - | - | - | - | - |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | -189.15K | -31.12K | -1.02M | -163.15K | -1.43M | -2.24M | -3.34M | -2.89M | -1.77M | -198.43K | -1.26M | -1.61M |
| Operating Margin % | -3.46% | -0.59% | -21.92% | -2.9% | -33.2% | -56.56% | -103.73% | -88.67% | -45.33% | -3.95% | -32.37% | -43.46% |
| Operating Income Growth % | 81.5% | 80.92% | 28.65% | 92.71% | 57.04% | 22.71% | -88.09% | -1358.93% | -40.81% | 87.69% | 24.52% | 34.25% |
| EBITDA | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA Margin % | - | - | 0% | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 100% | - | - | - | - | - | - | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 189.15K | 31.12K | 1.02M | 163.15K | 1.43M | 2.24M | 3.34M | 2.89M | 1.77M | 198.43K | 1.26M | 1.61M |
| EBIT | -189.15K | -31.12K | -1.02M | -163.15K | -1.43M | -2.24M | -3.34M | -2.89M | -1.77M | -198.43K | -1.26M | -1.61M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | 85.25M | 99.7M | -26.83M | 83.16M | -79.18M | -115.05M | 66.61M | 88.57M | 193.17M | 48.03M | -60.9M | -84.39M |
| Pretax Margin % | 1560.21% | 1879.21% | -575.22% | 1477.71% | -1834.99% | -2908.41% | 2071.36% | 2712.92% | 4938.03% | 956.56% | -1565.27% | -2274.64% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 85.25M | 99.7M | -26.83M | 83.16M | -79.18M | -115.05M | 66.61M | 88.57M | 193.17M | 48.03M | -60.9M | -84.39M |
| Net Margin % | 1560.21% | 1879.21% | -575.22% | 1477.71% | -1834.99% | -2908.41% | 2071.36% | 2712.92% | 4938.03% | 956.56% | -1565.27% | -2274.64% |
| Net Income Growth % | 417.76% | 19.88% | 66.12% | 172.29% | -218.88% | -229.9% | -65.52% | 84.4% | 417.19% | 156.91% | -145.21% | -28.83% |
| Net Income (Continuing) | 85.25M | 99.7M | -26.83M | 83.16M | -79.18M | -115.05M | 66.61M | 88.57M | 193.17M | 48.03M | -60.9M | -84.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.59 | 1.97 | -0.53 | 1.72 | -1.64 | -2.48 | 1.44 | 1.98 | 4.33 | 1.11 | -1.41 | -1.99 |
| EPS Growth % | 400% | 14.53% | 67.68% | 169.35% | -213.89% | -225.25% | -66.74% | 78.38% | 407.09% | 155.78% | -144.9% | -25.95% |
| EPS (Basic) | 1.59 | 1.97 | -0.53 | 1.72 | -1.64 | -2.48 | 1.44 | 1.98 | 4.33 | 1.11 | -1.41 | -1.99 |
| Diluted Shares Outstanding | 53.63M | 50.62M | 50.53M | 48.35M | 48.34M | 46.34M | 46.2M | 44.65M | 44.66M | 43.08M | 43.31M | 42.34M |
| Basic Shares Outstanding | 53.63M | 50.62M | 50.53M | 48.35M | 48.34M | 46.34M | 46.2M | 44.65M | 44.66M | 43.08M | 43.31M | 42.34M |
| Dividend Payout Ratio | 19.68% | - | - | - | - | - | - | - | - | - | - | - |